APC Therapeutics licensed its small-molecule anticancer compound to Glenmark Pharmaceuticals to further its development.
Exact Sciences announced a partnership with professional golfer Jerry Kelly to promote Cologuard.
The European Committee for Medicinal Products for Human Use issued a positive opinion of AbbVie’s hepatitis C treatment, Maviret.
Zacks analysts issued an updated research report on Allergan stating the company’s latest acquisitions of LifeCell and Zeltiq reaffirmed its commitment to acquisitions.
Valeant’s shares rose 7.8 percent on June 26 over rumors of a possible debt swap.
The emergence of Trulance, an alternative to Ironwood’s and Allergan’s Linzess, is worrying market analysts about Ironwood’s future prospects
More articles on gastroenterology:
Analysts predict the uncertain future of Ironwood Pharmaceuticals — 4 insights
GI center to know: Gastroenterology Associates
GI leader to know: Dr. Steven Condron of Avera Medical Group
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.